Clinvest Research Gets Fresh Focus Under New Ownership

Clinvest Research Gets Fresh Focus Under New Ownership

The development of new therapeutic drugs takes years of research and clinical trials. This fact is not surprising, but what may surprise people is that many of those treatments are tested right here in Springfield. What was founded as a small headache clinic by Dr. Roger Cady in 1996 has grown into a nationwide leader in clinical research now under the ownership and direction of his son Ryan Cady.

Ryan has been involved in clinical research for more than a decade, and has a strong commitment to the continued success of Clinvest Research. Over the years Clinvest Research, together with its sister clinic Headache Care Center, focused much of its effort on advancing treatment of head pain. This commitment to headache research will continue through a strong partnership with the now-independent Headache Care Center. However, Ryan Cady’s vision goes well beyond that of headaches.

By working with a team of local physicians, Clinvest plans to provide patients with access to some of the newest research in multiple areas, including migraine, Alzheimer’s, fibromyalgia, arthritis and cluster headache. Over the coming months their goal is to expand therapeutic reach to include additional disease states while continuing their commitment to excellence in research.

Says Ryan Cady, “We are thankful to be part of these cutting edge research studies and are excited to offer unique opportunities to advance medicine to those living in the Ozarks.”

About Clinvest

Clinvest is a research organization dedicated to the advancement of medicine and health management through clinical research. Founded by Dr. Roger Cady in 1996, Clinvest began as a research office associated with a small, independent primary care and headache specialty clinic located in Springfield, Missouri. Dr. Cady’s vision was to explore concepts sparked by information gathered in a clinical setting. Combining his clinical expertise in headache and his understanding of the value of patient reporting, Clinvest was formed. The results of many of those early migraine trials have revolutionized our understanding and treatment of migraine today.

Clinvest is a dedicated medical research facility that’s passionate about new concepts for disease control and prevention. We work with some of the nation’s top headache specialists, as well as other specialty physicians in the Springfield, Missouri area. We conduct FDA Phase II-IV research at our conveniently located, state-of-the-art facility. The majority of the research studies conducted at Clinvest are multi-center national or world-wide studies involving hundreds to thousands of participants. Our dedicated team of research professionals is committed to excellence, making us a leader in the field of Clinical Research. Clinvest Clinical Research has conducted more than 400 clinical trials sponsored by leading global pharmaceutical companies in a number of research areas including headache, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimer’s disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory bio-markers, and hyperlipidemia.